
Chipiron is developing scalable MRI technologies with the goal of making MRI 100x more accessible to enable widespread early diagnosis and image-guided therapies for deadly diseases. Their innovative…

Chipiron is developing scalable MRI technologies with the goal of making MRI 100x more accessible to enable widespread early diagnosis and image-guided therapies for deadly diseases. Their innovative…
Headquarters: Paris
Product: Ultra-low-field (ULF) compact MRI systems (breast-focused initially)
Recent funding: $17M Series A (Apr 30, 2025)
Founders: Evan Kervella; Dimitri Labat
Medical imaging accessibility; reducing cost and infrastructure requirements for MRI
2020
Medical Equipment Manufacturing
$17M
Announced to accelerate deployment and build clinical prototypes
“Company raised a $17M Series A led by Blast and lists multiple strategic/public investors including public innovation grants”
Required Skills & Profile
Technical Skills
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
81,000+
Open Roles
4,600+
New This Week
| Company |
|---|
Education & Experience
Soft Skills
Application Materials
Please submit:
Location: Centre for Magnetic Resonance of Biological Systems (RMSB, UMR 5536), University of Bordeaux, France, in close collaboration with Chipiron (Paris)
Contract
Scientific Supervisor: Prof. Eric Thiaudière, University of Bordeaux (eric.thiaudiere@u-bordeaux.fr)
Industrial Supervisor: Dr. Dimitri Labat, Chipiron (dimitri@chipiron.co)
About The Project – REACH
REACH is an industrial–academic R&D project dedicated to the construction of a low-field MRI demonstrator. Funded by Bpifrance, the project brings together Chipiron (Paris, chipiron.co) and the Centre for Magnetic Resonance at the University of Bordeaux (rmsb.u-bordeaux.fr).
The application context of the project is the development of a preclinical MRI system for small-animal imaging, with the objective of breast cancer detection, monitoring, and the optimized integration of contrast agents.
Research Objectives
The objective of this position is to achieve full operability of a new low-field MRI instrument, enabling the acquisition of high-quality images under preclinical conditions, with acquisition times compatible with in vivo small-animal imaging.
The system is composed of:
The recruited researcher will be responsible for ensuring communication between the different system components, enabling the design and implementation of acquisition protocols. This work will be carried out in close collaboration with a second researcher specialized in MRI methods, to jointly develop acquisition and post-processing solutions.
Scientific Scope & Themes
This project lies at the intersection of:
within a strong university–industry collaboration framework.
Main Activities
Research Environment
The RMSB (UMR 5536) has recognized expertise in low-field MRI, particularly Overhauser-enhanced MRI (OMRI).
The research environment includes:
https://www.ibisa.net/plateformes/plateforme-imagerie-biomedicale-pibio-107.html
Career Development & Impact
Given the industry–university cooperative nature of the project, the recruited researcher will consolidate their expertise to pursue careers as:
in a wide range of environments, in both the public and private sectors.
Working Conditions & Safety